FDA Inspection
Vertex Pharmaceuticals IncorporatedVertex Pharmaceuticals Incorporated – FDA Inspection, Mar 3, 2026
Record Details
This FDA Inspection record concerns Vertex Pharmaceuticals Incorporated, with an inspection on March 3, 2026, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · bc146f43-1e81-4339-a15b-d826e903c323
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1306258
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Vertex Pharmaceuticals Incorporated
14| Date | Classification | Office | Project area |
|---|---|---|---|
| July 31, 2026 | Not classified | New England District Office | |
| August 1, 2024 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| May 4, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 19, 2022 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| October 5, 2017 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Vertex Pharmaceuticals Incorporated
- FDA Inspection 1333028 - 2026-07-31
- FDA Inspection 1246447 - 2024-08-01
- FDA Inspection 1205834 - 2023-05-04
- FDA Inspection 1180001 - 2022-08-19
- FDA Inspection 1029564 - 2017-10-05
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.